Circadian subsidiary submits IND application to FDA to initiate VGX-100 study against

[News]

Circadian Technologies Limited is extremely proud to announce that its 100% owned subsidiary, Vegenics Pty Ltd, has submitted an investigational new drug application to the U.S. Food and Drug Administration to initiate clinical studies of VGX-100.

More... (http://www.news-medical.net/news/20111001/Circadian-subsidiary-submits-IND-application-to-FDA-to-initiate-VGX-100-study-against-cancer.aspx)